| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
|---|---|---|---|---|---|
Gross Sales | 3,085.51 | 3,040.21 | 3,611 | 3,638.56 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,085.51 | 3,040.21 | 3,611 | 3,638.56 | 0 |
Other Operating Income | 40.84 | 21.15 | 16.71 | 15.05 | 0 |
Other Income | 29.46 | 25.87 | 24.37 | 22.3 | 0 |
Total Income | 3,155.81 | 3,087.23 | 3,652.08 | 3,675.91 | 0 |
Total Expenditure | 2,754.01 | 2,731.48 | 3,182.67 | 2,964.19 | 0 |
PBIDT | 401.8 | 355.75 | 469.41 | 711.72 | 0 |
Interest | 41.73 | 39.04 | 15.88 | 24.82 | 0 |
PBDT | 360.07 | 316.71 | 453.53 | 686.9 | 0 |
Depreciation | 118.24 | 100.45 | 92.34 | 92.47 | 0 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 59.99 | 41.29 | 58.73 | 108.36 | 0 |
Deferred Tax | 4.72 | 21.33 | 47.27 | 77.95 | 0 |
Reported Profit After Tax | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 177.12 | 153.64 | 255.19 | 408.12 | 0 |
EPS (Unit Curr.) | 11.2 | 9.71 | 16.05 | 25.67 | 0 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 250 | 250 | 250 | 250 | 0 |
Equity | 15.81 | 15.8 | 15.9 | 15.9 | 0.05 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 13.02 | 11.7 | 12.99 | 19.56 | 0 |
PBDTM(%) | 11.66 | 10.41 | 12.55 | 18.87 | 0 |
PATM(%) | 5.74 | 5.05 | 7.06 | 11.21 | 0 |
The board approved this acquisition on December 30, 2024. The equity bought of 6.67% was from Hero Fincorp Ltd and Sunil Kant Munjal.
In Q2 FY25, the company's total EBITDA increased by 7% year on year to ₹135 Crore, up from ₹126 Crore the previous year.
The company stated that its production facility in Bharuch successfully completed its USFDA inspection with zero 483 findings.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
